Jaksch Frank L Jr
- SEC CIK
- 0001437237
No open-market purchases or sales filed in the past year.
Current role at each company
- NAGE Niagen Bioscience, Inc.Directoras of Jun 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jaksch Frank L Jr as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 (view filing) | Dec 13 | Same day | Jaksch Frank L JrDirector | SSale | −37.2K | $6.19 | −$230.0K | −13.2%244.2K after | |
| Jun 13, 2023 (view filing) | Jun 12 | 1 day | Jaksch Frank L JrDirector | PPurchase | +7.00K | $1.69 | +$11.8K | +3.1%231.3K after |